Published on

Clinical Toxicology — Pyrethrins, Pyrethrum, and Pyrethroids

1. Overview

Pyrethrins and pyrethroids are widely used insecticides encountered in household pest-control products, agricultural preparations, insect sprays, mosquito-control programs, and some medications for head lice.

Pyrethrum is an extract obtained from certain chrysanthemum flowers. Pyrethrins are six naturally occurring insecticidal compounds present in this extract. Pyrethroids are synthetic chemicals developed to reproduce or improve the insecticidal properties of pyrethrins.

Most minor accidental human exposures cause transient irritation or no symptoms. However, concentrated products and substantial ingestions can cause serious neurotoxicity, including tremors, muscle fasciculations, seizures, and coma.

Inhaled sprays may produce respiratory irritation, while formulations containing hydrocarbon solvents can cause potentially severe aspiration pneumonitis.

The principal treatment is supportive care, including removal from exposure, decontamination, respiratory support when needed, and benzodiazepines for seizures.

There is no specific antidote for pyrethrin or pyrethroid poisoning.

2. Chemical forms and uses

Natural pyrethrins

Natural pyrethrins are extracted primarily from Tanacetum cinerariifolium, historically classified as Chrysanthemum cinerariifolium.

The six principal insecticidal constituents are:

  • Pyrethrin I and II.
  • Cinerin I and II.
  • Jasmolin I and II.

Natural pyrethrins degrade relatively rapidly in sunlight and the environment.

They are used in selected insect sprays, household products, agricultural pesticides, and pharmaceutical head-lice treatments.

Synthetic pyrethroids

Common synthetic pyrethroids include permethrin, cypermethrin, deltamethrin, cyfluthrin, lambda-cyhalothrin, bifenthrin, fenvalerate, resmethrin, and phenothrin.

Pyrethroids differ in potency, persistence, toxicity, and clinical effects. They should not be treated as identical compounds.

Synergists and inactive ingredients

Many commercial insecticides contain piperonyl butoxide (PBO), a synergist that inhibits certain metabolic processes in insects and increases insecticidal effectiveness.

Other ingredients may include petroleum distillates, solvents, fragrances, surfactants, or propellants.

These components can contribute substantially to toxicity.

The precise product name, ingredient concentrations, and formulation are therefore essential to clinical assessment.

3. Mechanism of toxicity

Neuronal sodium-channel effects

Pyrethrins and pyrethroids act primarily by altering voltage-gated sodium channels in nerve membranes.

They delay normal channel inactivation or closure, allowing prolonged sodium influx and repetitive neuronal firing.

In insects, this produces rapid neurologic dysfunction and paralysis.

In mammals, excessive exposure can produce abnormal sensory symptoms, tremor, and central nervous system excitation.

Type I pyrethroids

Type I pyrethroids generally lack an alpha-cyano group.

Examples include permethrin and resmethrin.

Severe toxicity is associated predominantly with the T syndrome, characterized by fine tremor, reflex hyperexcitability, and increased responsiveness to stimulation.

Type II pyrethroids

Type II pyrethroids contain an alpha-cyano group.

Examples include deltamethrin, cypermethrin, and lambda-cyhalothrin.

Severe toxicity is associated with the CS syndrome, which may include profuse salivation, coarse tremors, choreoathetoid movements, incoordination, and seizures.

These categories describe characteristic experimental and clinical patterns; individual poisoning presentations may overlap.

Additional mechanisms

Some pyrethroids also affect chloride channels and GABA-related inhibitory neurotransmission, particularly at high concentrations.

Why human toxicity is usually limited

Mammals are generally less sensitive than insects because of differences in neuronal channel sensitivity, body temperature, and metabolic detoxification.

Rapid metabolism and relatively limited absorption through intact skin also reduce systemic toxicity under ordinary use conditions.

However, these protective factors can be overwhelmed by concentrated formulations or substantial exposures.

4. Toxic dose and risk factors

There is no universally reliable toxic-dose threshold.

Toxicity depends on the specific compound, formulation strength, route, amount absorbed, and patient characteristics.

The older estimate of 100–1,000 mg/kg should not be used as a clinical cutoff for deciding whether an exposure is safe.

A small exposure to a dilute household spray differs significantly from ingestion of a concentrated agricultural preparation.

Important risk factors include:

  • Ingestion of concentrated insecticide.
  • Exposure to petroleum-based solvents.
  • Application in confined or poorly ventilated spaces.
  • Repeated or prolonged occupational exposure.
  • Accidental misuse of flea and tick products.
  • Coexposure to organophosphate or carbamate insecticides.
  • Preexisting respiratory illness.
  • Inability to communicate symptoms, particularly in young children.

Children

Children may experience higher exposure relative to body weight and are vulnerable to accidental ingestion or misuse of topical products.

However, a universal statement that children cannot metabolize pyrethrins adequately is not supported as a clinical rule.

Risk should be assessed according to the specific exposure rather than age alone.

5. Clinical manifestations

Skin effects

Dermal contact may cause burning, stinging, itching, tingling, or numbness.

These sensory symptoms are often referred to as pyrethroid-induced paresthesia.

The face, hands, arms, and neck are commonly affected.

Symptoms may occur with little or no visible skin inflammation.

They generally resolve within approximately 24 hours after exposure ceases.

Dermatitis

Some formulations cause redness, irritation, or contact dermatitis.

True allergic contact dermatitis is less firmly established than the earlier literature suggested.

Eye effects

Eye contamination may produce burning, pain, tearing, redness, and temporary visual disturbance.

Significant ocular injury can result from concentrated products or irritating solvents.

Respiratory effects

Inhalation of sprays, aerosols, or dusts can cause:

  • Nasal irritation and rhinorrhea.
  • Sneezing.
  • Throat irritation.
  • Cough.
  • Chest tightness.
  • Wheezing.
  • Shortness of breath.

Serious respiratory compromise is uncommon after minor exposure but can occur following substantial exposure or complications involving solvents.

Gastrointestinal effects

Ingestion may cause nausea, vomiting, abdominal cramping, diarrhea, and excessive salivation.

Persistent or severe symptoms require assessment for systemic toxicity and formulation-related complications.

Neurologic effects

Moderate or severe poisoning can cause headache, dizziness, tingling, tremor, incoordination, and muscle fasciculations.

Severe poisoning may produce agitation, abnormal involuntary movements, recurrent seizures, impaired consciousness, and coma.

Cardiovascular effects

Tachycardia may occur in association with agitation, seizures, or systemic toxicity.

Major cardiac dysrhythmias are not a defining feature of typical pyrethroid poisoning. Their presence should prompt assessment for severe illness, electrolyte disturbances, solvents, or another insecticide.

6. Respiratory hypersensitivity and allergic reactions

Natural pyrethrum extracts historically have been associated with rhinitis, asthma-like symptoms, and occasional reports of severe hypersensitivity.

However, the evidence that pyrethrins or pyrethroids consistently cause allergic sensitization or asthma is inconclusive.

A U.S. EPA review found no clear and consistent overall association.

Similarly, the proposed cross-reactivity between ragweed allergy and modern refined pyrethrins is not sufficiently established to serve as a reliable risk predictor.

Practical interpretation

Patients can still experience clinically important bronchospasm or hypersensitivity after exposure.

Treatment should follow the actual clinical findings.

Severe wheezing, respiratory distress, or anaphylaxis requires immediate management regardless of whether the mechanism is irritant or immunologic.

7. Hydrocarbon solvent toxicity

This is one of the most important complications of commercial insecticide ingestion.

Many liquid pesticide products use petroleum distillates or other hydrocarbon solvents.

Aspiration pneumonitis

Vomiting, depressed consciousness, or inappropriate gastrointestinal decontamination may allow these liquids to enter the lungs.

Hydrocarbon aspiration can cause:

  • Cough and choking.
  • Wheezing.
  • Hypoxemia.
  • Chemical pneumonitis.
  • Pulmonary infiltrates.
  • Severe respiratory failure.

Clinical implication

A patient may develop major pulmonary toxicity from a pyrethroid product even when the pyrethroid itself would not have caused severe systemic poisoning.

The presence of hydrocarbon solvents must be considered before any gastrointestinal decontamination procedure.

8. Differential diagnosis

The most important alternative diagnosis is organophosphate or carbamate insecticide poisoning.

Both conditions can produce salivation, gastrointestinal symptoms, muscle fasciculations, respiratory complaints, and seizures.

Organophosphate poisoning

Organophosphates inhibit acetylcholinesterase, causing accumulation of acetylcholine.

Characteristic manifestations may include miosis, bronchorrhea, bradycardia, profuse sweating, diarrhea, muscle weakness, and respiratory failure.

Pyrethroid poisoning

Pyrethroids primarily disrupt neuronal ion-channel activity.

Paresthesia, tremor, hyperexcitability, and abnormal involuntary movements are useful diagnostic clues.

Mixed formulations

Some pesticide products contain more than one active insecticide.

Mixed exposure may produce overlapping clinical syndromes.

Other differential diagnoses

Consider hydrocarbon aspiration, solvent toxicity, nicotine-containing insecticides, other neurotoxic pesticides, asthma exacerbation, and alternative causes of seizures or altered consciousness.

A pesticide label or reliable formulation identification is often more useful than trying to diagnose the pesticide class from symptoms alone.

9. Diagnostic evaluation

Exposure history

Determine the product name, active ingredients, concentrations, amount, exposure route, and estimated time of contact.

Ask whether the product was sprayed, swallowed, inhaled, or applied to skin.

Determine whether it contained petroleum solvents, piperonyl butoxide, or other insecticides.

Mild exposure

No laboratory investigations are routinely required for mild skin irritation or transient symptoms after a clearly identified low-risk product.

Significant poisoning

Depending on the presentation, obtain:

  • Vital signs and oxygen saturation.
  • Blood glucose.
  • Electrolytes and kidney function.
  • ECG.
  • Blood gas and lactate when severe respiratory or neurologic toxicity is present.
  • Creatine kinase following prolonged seizures or muscle activity.
  • Chest radiography for persistent cough, hypoxemia, or suspected aspiration.

Cholinesterase testing

When organophosphate or carbamate poisoning is possible, plasma or red-cell cholinesterase testing may help clarify the diagnosis.

Normal cholinesterase activity is generally expected in isolated pyrethroid poisoning.

Testing should not delay resuscitation.

Pyrethroid measurements

Specialized laboratories can measure certain pyrethroid metabolites in urine.

These tests are primarily useful for occupational or environmental exposure assessment.

They are not routinely available rapidly enough to guide emergency treatment and do not provide validated clinical severity thresholds.

10. Treatment

Immediate management

Remove the patient from further exposure.

Assess airway, breathing, circulation, consciousness, and seizure activity.

Severe respiratory distress, coma, or seizures require emergency resuscitation.

Contact a poison control center or medical toxicologist for substantial or uncertain exposures.

Inhalation

Move the patient to fresh air without exposing rescuers to a contaminated atmosphere.

Give supplemental oxygen when indicated by hypoxemia or significant respiratory compromise.

Treat bronchospasm with inhaled bronchodilators such as albuterol.

Persistent wheezing may require conventional asthma-exacerbation treatment, including corticosteroids when clinically indicated.

Corticosteroids are not routinely recommended merely because pyrethroid inhalation occurred.

Skin decontamination

Remove contaminated clothing.

Wash exposed skin thoroughly with soap and water.

Avoid harsh scrubbing or chemical solvents, which may worsen irritation.

Paresthesia

Localized paresthesia generally resolves spontaneously.

The EPA pesticide-poisoning manual describes benefit from topical vitamin E oil preparations, although supporting clinical evidence is limited and this is not a treatment for systemic poisoning.

Persistent or severe sensory symptoms warrant reassessment.

Eye exposure

Irrigate immediately with water or saline.

Continue irrigation for approximately 15–20 minutes or longer when needed.

Persistent pain, visual disturbance, or significant redness requires ophthalmologic assessment.

11. Gastrointestinal decontamination

Induced vomiting

Do not induce vomiting.

Aspiration of hydrocarbon-containing formulations can produce severe lung injury.

Gastric lavage

Routine gastric lavage is not recommended.

It can increase aspiration risk and has no established clinical benefit for ordinary pyrethroid poisoning.

Activated charcoal

A single dose may be considered after a substantial recent ingestion when the expected benefit outweighs the risk and the airway is protected.

However, charcoal is generally unnecessary for minor exposures.

When hydrocarbon solvent toxicity is the predominant concern, charcoal has no meaningful benefit for the solvent and may increase aspiration risk.

Activated charcoal must not be given to a vomiting, obtunded, or otherwise unprotected patient.

Cathartics

Routine cathartics are not recommended.

Multiple-dose charcoal

There is no established role for routine multiple-dose activated charcoal.

12. Severe neurotoxicity and seizures

Seizure treatment

Benzodiazepines are first-line therapy.

Lorazepam, midazolam, or diazepam may be used according to standard emergency seizure protocols.

Refractory seizures

Persistent seizures require escalation according to status epilepticus guidelines.

Airway protection, mechanical ventilation, and continuous EEG monitoring may be necessary.

Tremors and severe agitation

Benzodiazepines may also be useful for pronounced tremor or hyperexcitability.

Rhabdomyolysis

Prolonged muscle activity or seizures may cause muscle injury.

Check CK, electrolytes, and kidney function when clinically indicated.

Important limitation

There is no established pyrethroid-specific antidotal treatment for seizures.

Anticonvulsants and supportive critical care remain central.

13. Atropine and pralidoxime

Atropine

Atropine is the principal antidote for severe muscarinic manifestations of organophosphate poisoning.

It is not a specific antidote for pyrethroid poisoning.

Isolated type II pyrethroid poisoning may cause marked salivation, potentially leading to diagnostic confusion.

Routine atropine administration can produce tachycardia, hyperthermia, delirium, urinary retention, and other antimuscarinic complications.

Although selected historical reports describe low-dose atropine for severe secretions, this should not be regarded as standard treatment for all pyrethroid exposures.

Pralidoxime

Pralidoxime is used in selected organophosphate poisonings to reactivate inhibited acetylcholinesterase.

It has no established role in isolated pyrethroid poisoning.

Mixed pesticide exposure

If organophosphate poisoning cannot be excluded in a critically ill patient, treatment must be based on the overall presentation and expert toxicology guidance.

Do not withhold necessary resuscitation while awaiting laboratory confirmation.

14. Chemical pneumonitis

Aspiration of hydrocarbon-containing insecticide may cause chemical inflammation of the lungs.

Management

Provide oxygen and respiratory support according to severity.

Inhaled bronchodilators may be appropriate for associated bronchospasm.

Severe cases may require mechanical ventilation.

Antibiotics

Prophylactic antibiotics are not routinely recommended.

Antibiotics should be considered when secondary bacterial infection is suspected or demonstrated.

Corticosteroids

Routine systemic corticosteroids are not recommended solely to treat hydrocarbon aspiration pneumonitis.

15. Observation and disposition

Minor exposure

Patients with mild, resolving skin, eye, or upper-airway irritation may be managed after appropriate decontamination and risk assessment.

Significant ingestion

Observe for neurologic, gastrointestinal, and respiratory complications.

The appropriate duration depends on the compound, formulation, symptoms, and potential for aspiration.

Respiratory symptoms

Patients with persistent cough, wheezing, chest discomfort, tachypnea, or hypoxemia require clinical evaluation.

Chest imaging and longer observation may be appropriate when aspiration or chemical pneumonitis is suspected.

Hospital admission

Admission is appropriate for:

  • Persistent respiratory symptoms.
  • Hypoxemia.
  • Chemical pneumonitis.
  • Recurrent seizures.
  • Marked tremor or neurologic dysfunction.
  • Altered consciousness.
  • Significant dehydration.
  • Major or uncertain pesticide ingestion requiring continued monitoring.

Intensive care

ICU care is indicated for status epilepticus, coma, respiratory failure, severe aspiration injury, or other life-threatening complications.

Discharge

Discharge requires stable vital signs, reassuring respiratory and neurologic findings, adequate observation for the formulation involved, and clear instructions for returning if symptoms worsen.

A fixed four- to six-hour rule should not substitute for assessment of solvent-related aspiration risk or severe systemic toxicity.

16. Expected course and prognosis

Most uncomplicated pyrethrin and pyrethroid exposures resolve completely.

Dermal paresthesias often improve within 24 hours.

Mild respiratory or gastrointestinal irritation generally resolves over hours to a few days.

Severe systemic poisoning may require several days of supportive treatment.

Persistent neurologic complications are unusual but have been described after severe intoxication.

Chemical pneumonitis may have a longer recovery period, depending on the extent of aspiration injury.

Fatal outcomes are rare relative to the frequency of exposure but can occur after severe ingestion, recurrent seizures, respiratory failure, or other complications.

17. Pregnancy, lactation, and occupational exposure

Pregnancy

The old FDA Pregnancy Category C classification is not a useful general classification for this broad insecticide group.

Risk depends on the exact compound, dose, formulation, and exposure route.

An isolated minor exposure does not automatically imply fetal injury.

Significant maternal poisoning requires prompt treatment of hypoxemia, seizures, and other complications, with obstetric involvement when appropriate.

Lactation

Risk assessment should distinguish minor environmental exposure from ingestion or significant systemic poisoning.

Lactation advice should follow the exact ingredient and product rather than assuming uniform transfer into breast milk.

Occupational limits

For pyrethrum, OSHA’s permissible exposure limit and NIOSH’s recommended exposure limit are each 5 mg/m³ as an eight-hour time-weighted average.

This limit applies to pyrethrum and must not be generalized to every synthetic pyrethroid.

Prevention

Occupational exposure prevention should prioritize engineering controls, ventilation, safe handling procedures, and appropriate protective clothing.

Respirator selection must follow the specific product, concentration, and workplace respiratory-protection program.

18. Prevention and patient education

Use pesticides only according to the product label.

Avoid applying agricultural concentrates indoors or using veterinary formulations on humans.

Do not exceed recommended concentrations or mix pesticides without explicit product instructions.

Provide adequate ventilation during application and observe reentry restrictions.

Wear appropriate gloves and eye protection.

Wash hands after handling insecticides.

Store products in their original labeled containers, away from children, food, and medicines.

Do not transfer pesticide solutions into beverage bottles.

Important pet safety

Permethrin-containing dog flea and tick products can be extremely toxic to cats.

Dog-specific products must not be applied to cats unless explicitly approved for that species.

Cats exposed to concentrated permethrin may develop severe tremors, seizures, and potentially fatal poisoning.

Such exposure requires urgent veterinary assessment.

19. Clinical pitfalls

  • Treating pyrethroid poisoning as primarily allergic: Its principal systemic mechanism is neuronal ion-channel disruption.
  • Assuming ragweed allergy reliably predicts severe poisoning: The proposed cross-reactivity is not supported consistently.
  • Ignoring formulation ingredients: Hydrocarbon solvents and other pesticides may dominate clinical risk.
  • Using fixed oral toxic-dose thresholds: The toxicity of pyrethroids varies substantially.
  • Confusing pyrethroids with organophosphates: Salivation, fasciculations, and seizures can overlap, but the mechanisms differ.
  • Administering atropine reflexively: Atropine is not an antidote for isolated pyrethroid poisoning.
  • Using pralidoxime automatically: It is not indicated for isolated pyrethroid exposure.
  • Inducing vomiting: This can cause aspiration pneumonitis.
  • Performing routine gastric lavage: Clinical benefit is unproven and aspiration risk is significant.
  • Giving activated charcoal to every patient: Use should be selective and must account for solvents and airway protection.
  • Missing pyrethroid-induced paresthesia: Burning or tingling may occur without visible dermatitis.
  • Assuming every respiratory symptom is anaphylaxis: Airway irritation, bronchospasm, and aspiration pneumonitis require different assessment.
  • Missing delayed respiratory complications: Significant aspiration injury may evolve after the initial exposure.
  • Assuming a fixed observation period is universally safe: Disposition depends on the formulation, route, and clinical course.

20. Classification

Historically, ICD-9-CM 989.4 classified toxic effects of certain pesticides.

Contemporary coding should identify pesticide poisoning or adverse exposure, intent, route, and associated complications when documented.

Relevant diagnoses may include pesticide-induced dermatitis, bronchospasm, chemical pneumonitis, toxic encephalopathy, seizures, and respiratory failure.


Key clinical conclusions

Pyrethrins and pyrethroids generally have lower acute mammalian toxicity than many older insecticide classes, but concentrated exposures can cause severe neurologic and respiratory complications.

Type I pyrethroids are classically associated with tremor and reflex hyperexcitability, whereas type II compounds may produce prominent salivation, abnormal movements, and seizures.

The formulation must always be identified because hydrocarbon solvents and additional insecticides may contribute substantially to toxicity.

There is no specific antidote. Treatment consists of exposure termination, skin and eye decontamination, airway and respiratory support, and benzodiazepines for significant neurotoxicity.

Avoid routine vomiting induction, gastric lavage, activated charcoal, atropine, or pralidoxime in isolated pyrethroid exposures unless a separate clinical indication exists.


Image description
0 Comments